Hematopoietic Stem C
Hematopoietic Stem Cell Transplantation - Global Clinical Trials Review, H2, 2015: ResearchMoz
March 23, 2016 09:00 ET | Researchmoz Global Pvt Ltd
Albany, NY, March 23, 2016 (GLOBE NEWSWIRE) -- The report aims to help readers make effective business strategies by understanding the prevalent hematopoietic stem cell transplantation market...
Mesenchymal Stem Cel
Mesenchymal Stem Cells Market Advances and Applications – Market Growth and Future Analysis: ResearchMoz
March 22, 2016 08:00 ET | Researchmoz Global Pvt Ltd
Albany, NY, March 22, 2016 (GLOBE NEWSWIRE) -- The report explores the recent advancements in mesenchymal stem cell research applications and the competitive environment in the market. It further...
Coriell Institute for Medical Research Logo
Coriell Institute Licenses PluriTest(R), a Novel Stem Cell Technology
January 20, 2016 10:09 ET | Coriell Institute for Medical Research
CAMDEN, N.J., Jan. 20, 2016 (GLOBE NEWSWIRE) -- The Coriell Institute for Medical Research today announces the in-licensing of PluriTest, a cost-effective, accurate, animal-free bioinformatics assay...
Mesoblast Announces Pricing Of Public Offering On Nasdaq
November 13, 2015 08:38 ET | Mesoblast
NEW YORK and MELBOURNE, Australia, Nov. 13, 2015 (GLOBE NEWSWIRE) -- Mesoblast Limited (NASDAQ:MESO) (ASX:MSB), a world leader in the development of innovative cell-based medicines, today announced...
Genetics Policy Institute
GPI "Stem Cell Action Award" Honorees Announced for 2015
October 27, 2015 09:37 ET | Genetics Policy Institute
ATLANTA, Oct. 27, 2015 (GLOBE NEWSWIRE) -- Five distinguished honorees have been selected for the 2015 Stem Cell Action Awards. For 11 years, the Genetics Policy Institute (GPI) has honored the stem...
AmnioLife to Partici
AmnioLife to Participate at First Annual Interventional Orthopedic Foundation Conference October 23rd & 24th
October 06, 2015 05:00 ET | AmnioLife Corporation
GAINESVILLE, Fla., Oct. 06, 2015 (GLOBE NEWSWIRE) -- AmnioLife Corporation, a human cells, tissues, and cellular and tissue-based products developer, today announced that its CEO and Lead Scientist...
BioCardia-Final-Logo-2016-JPEG.jpg
BioCardia to Present at 2015 Stem Cell Meeting on the Mesa
October 05, 2015 20:32 ET | BioCardia, Inc.
SAN CARLOS, Calif., Oct. 05, 2015 (GLOBE NEWSWIRE) -- BioCardia, Inc., a  clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases announced...
Super Cells: The Power of Stem Cells Opens Today at MaRS TORONTO, ON--(Marketwired - October 05, 2015) - A new science exhibit, created in both French and English, opens today at MaRS Discovery District in downtown Toronto. Super Cells: The Power of Stem...
Phase 2 Trial Results Show Mesoblast Cell Therapy Has Greatest Cardioprotective Effect In Patients With Advanced Heart Failure
September 29, 2015 21:10 ET | Mesoblast
NEW YORK and MELBOURNE, Australia, Sept. 29, 2015 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX: MSB; USOTC:MBLTY) today announced that additional Phase 2 trial results of its lead product candidate for...
1.Neural-0.5mm-scale-bar
Stem cell-derived 'organoids' help predict neural toxicity
September 21, 2015 15:48 ET | Morgridge Institute for Research
MADISON, Wis., Sept. 21, 2015 (GLOBE NEWSWIRE) -- A new system developed by scientists at the Morgridge Institute for Research and the University of Wisconsin-Madison may provide a faster, cheaper and...